Kenya
Tuberculosis profile
| High TB burden | High HIV burden |
Population  2012 43 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 9.5 (5.4–15) 22 (13–34)
Mortality (HIV+TB only) 7.7 (6.6–8.9) 18 (15–21)
Prevalence  (includes HIV+TB) 130 (71–210) 299 (164–475)
Incidence  (includes HIV+TB) 120 (110–120) 272 (261–283)
Incidence (HIV+TB only) 45 (44–47) 105 (101–109)
Case detection, all forms (%) 79 (76–83)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 36 937 (41) Relapse 3 419 (36)
Smear-negative 28 574 (32) Treatment after failure 326 (3)
Smear-unknown / not done 8 123 (9) Treatment after default 1 408 (15)
Extrapulmonary 15 934 (18) Other 4 428 (46)
Other 0 (0)      
Total new 89 568   Total retreatment 9 581  
           
Other (history unknown) 0        
Total new and relapse 92 987   Total cases notified 99 149  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.6 1.2 1.2
Age < 15 996 1 907 2 465
Laboratories 2012
Smear (per 100 000 population) 4.2
Culture (per 5 million population) 0.2
Drug susceptibility testing (per 5 million population) 0.2
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 88   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 85  
Retreatment 82  
TB/HIV 2012 Number (%)
TB patients with known HIV status 92 890 (94)
HIV-positive TB patients 35 837 (39)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 35 025 (98)
HIV-positive TB patients on antiretroviral therapy (ART) 26 487 (74)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.5 (0.01–5) 10 (3.5–17)
MDR-TB cases among notified pulmonary
TB cases
1 800 (7–3 700) 980 (340–1 600)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 78 (<1%) 1 183 (12%) 1 344
Laboratory-confirmed MDR-TB cases 9 205 225
Patients started on MDR-TB treatment     202
Financing TB control 2013
National TB programme budget (US$ millions) 55
% Funded domestically 24%
% Funded internationally 15%
% Unfunded 61%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data